902
R. Maura et al. / Journal of Organometallic Chemistry 696 (2011) 897e904
CHO
[Rh(acac)(CO)2]/1,3
CHO
+
+
+
H2
R
R
R
CO
R = C6H13
Scheme 4. The hydroformylation of 1-octene.
[NH3] MS m/z: 390 [M þ H]þ. Compound 4: 31P{1H} NMR
13C{1H} NMR (75.5 MHz, CDCl3): [
d
/ppm] 156.9 (d, 2JCP ¼ 4.1 Hz, C]
(121.5 MHz, C6D6): [
d
/ppm] 69.4 (s). 1H NMR (300.1 MHz, C6D6): [
d/
N), 150.3 (d, JCP ¼ 7.5 Hz, Ar), 148.5 (s, Ar), 139.5 (s, Ar), 135.9 (d,
JCP ¼ 78.9 Hz, Ar), 133.6 (d, JCP ¼ 52.1 Hz, Ar), 132.6 (d, JCP ¼ 10.5 Hz,
Ar), 131.4 (d, JCP ¼ 10.6 Hz, Ar), 130.1 (d, JCP ¼ 2.4 Hz, Ar), 129.9 (d,
JCP ¼ 2.3 Hz, Ar),128.1 (d, JCP ¼ 10.8 Hz, Ar),127.7 (d, JCP ¼ 9.7 Hz, Ar),
125.3 (s, Ar), 124.9 (s, Ar), 123.5 (s, Ar), 122.7 (s, Ar), 52.1 (d,
4JCP ¼ 1.0 Hz, NCH(CH3)2), 47.4 (s, NCH(CH3)2), 20.7 (s, NCH(CH3)2),
20.6 (s, NCH(CH3)2), 20.5 (s, NCH(CH3)2), 20.0 (s, NCH(CH3)2). DCI
[NH3] MS m/z: 418 [M þ H]þ. Mp: 160e164 ꢁC (dec.).
ppm] 8.58 (br d, JHH ¼ 4.8 Hz, 1H, Ar), 7.21 (ddd, JHH ¼ 7.8 Hz,
JHH ¼ 7.8 Hz, JHH ¼ 1.8 Hz,1H, Ar), 7.01 (brd, JHH ¼ 7.8 Hz,1H, Ar), 6.70
(ddd, JHH ¼ 7.5 Hz, JHH ¼ 4.8 Hz, JHH ¼ 0.9 Hz, 1H, Ar), 3.49 (h,
3JHH ¼ 6.9 Hz, 2H, NCH(CH3)2),1.94 (h, 3JHH ¼ 6.9 Hz, 2H, PCH(CH3)2),
3
3
1.40 (dd, JHH ¼ 6.9 Hz, JHP ¼ 10.0 Hz, 6H, PCH(CH3)2), 1.22 (dd,
3JHH ¼ 7.2 Hz, 3JHP ¼ 14.5 Hz, 6H, PCH(CH3)2),1.43e1.21 (m,12H, NCH
(CH3)2). RMN 13C{1H} (75.5 MHz, C6D6):
[d/ppm] 165.6 (d,
2JCP ¼ 29.0 Hz, C]N),157.1 (d, JCP ¼ 6.6 Hz, Ar),149.1 (d, JCP ¼ 0.6 Hz,
Ar), 135.0 (d, JCP ¼ 1.4 Hz, Ar), 122.6 (d, JCP ¼ 5.7 Hz, Ar), 121.9 (s, Ar),
48.0 (br s, NCH(CH3)2), 27.4 (d, 1JCP ¼ 12.7 Hz, PCH(CH3)2), 20.6 (s,
NCH(CH3)2),18.9 (d, 2JCP ¼ 19.5 Hz, PCH(CH3)2),18.2 (d, 2JCP ¼ 8.9 Hz,
PCH(CH3)2). DCI[NH3] MS m/z: 322 [M þ H]þ.
4.4. Preparation of N-phosphino amidines rhodium complexes 7
and 8
To a solution of [Rh(COD)Cl]2 (0.10 g, 0.20 mmol) in CH2Cl2
(4 mL) was added a solution of 0.40 mmol of ligand (1, 155 mg; 2,
128 mg) in CH2Cl2 (4 mL). The reaction mixture was stirred at room
temperature for 2 h. The solvent was removed and the resulting
yellow powder was washed with n-pentane (3 ꢂ 3 mL) to give 7 in
79% (200 mg, 0.32 mmol) yield and 8 in 83% yield (188 mg,
4.3. Preparation of N-phosphanylamidines 5 and 6
The 8.30 mL of n-BuLi (1.6 mol Lꢀ1, 13.30 mmol) were added
slowly at ꢀ78 ꢁC to
a solution of 2-bromopyridine (2.10 g,
13.30 mmol) in 20 mL of Et2O. The mixture was stirred for 1 h and
a solution of iPr2CN (2.02 mL, 13.30 mmol) in 8 mL of Et2O was
added. After 1 h at ꢀ40 ꢁC, Ph2PCl (2.40 mL,13.30 mmol) was added.
The reaction mixture was stirred for 1 h at ꢀ40 ꢁC and then allowed
to reach 0 ꢁC before the addition of BH3$THF (1.0 mol Lꢀ1, 13.30 mL,
13.30 mmol). The reaction mixture was stirred overnight at room
temperature. LiCl formed during the reaction was removed by
filtration and the crude product was then purified by column chro-
0.33 mmol). Compound 7: 31P{1H} NMR (121.5 MHz, CDCl3):
1
[
d
/ppm] 58.3 (d, JPRh ¼ 154.2 Hz). 1H NMR (200.1 MHz, CDCl3):
[d
/ppm] 7.64e7.53 (m, 5H, Ar), 7.34e7.14 (m, 10H, Ar), 5.26 (br s, 2H,
3
olefinic HCOD), 3.69 (m, 1H, NCH(CH3)2), 3.40 (h, JHH ¼ 6.7 Hz, 1H,
NCH(CH3)2), 3.18 (br s, 2H, olefinic HCOD), 2.35e2.06 (m, 4H,
aliphatic HCOD), 1.94e1.76 (m, 4H, aliphatic HCOD), 1.61 (d,
3JHH ¼ 6.9 Hz, 6H, NCH(CH3)2), 0.99 (d, JHH ¼ 6.7 Hz, 6H, NCH
3
(CH3)2). 13C{1H} NMR (50.3 MHz, CDCl3):
[d/ppm] 164.1 (d,
matography (eluent Et2O/pentane: 20/80). Compound
5
was
2JCP ¼ 8.6 Hz, C]N), 138.5 (d, J ¼ 46.0 Hz, Ar), 132.9 (d, J ¼ 11.9 Hz,
Ar), 128.5 (d, J ¼ 2.0 Hz, Ar), 128.4 (s, Ar), 127.2 (d, J ¼ 10.0 Hz, Ar),
126.8 (s, Ar),103.9 (dd, 1JCRh ¼ 6.2 Hz, 2JCP ¼ 12.9 Hz, CHCOD), 69.4 (d,
1JCRh ¼ 14.5 Hz, CHCOD), 51.3 (s, NCH(CH3)2), 46.6 (s, NCH(CH3)2),
32.7 (s, CH2COD), 28.4 (s, CH2COD), 20.6 (s, NCH(CH3)2), 20.1 (s, NCH
(CH3)2). DCI[CH4] MS m/z: 635 [M þ H]þ, 634 [M]þ. Compound 8:
obtained in 20% yield as a white powder. The side product 6 was
isolated in 7% yield. Compound 5: 31P{1H} NMR (121.5 MHz, CDCl3):
1
[
[
d
/ppm] 45.9 (br d, JPB ¼ 74.8 Hz). 1H NMR (200.1 MHz, CDCl3):
d
/ppm] 8.21 (d, JHH ¼ 5.1 Hz,1H, Ar), 7.81e7.04 (m,13H, Ar), 3.75 (m,
1H, NCH(CH3)2), 3.43 (m, 1H, NCH(CH3)2), 1.73 (d, 3JHH ¼ 6.6 Hz, 6H,
NCH(CH3)2), 1.13 (br s, 6H, NCH(CH3)2). 13C{1H} NMR (75.5 MHz,
31P{1H} NMR (121.5 MHz, C6D6): [
d
/ppm] 74.0 (d, 1JPRh ¼ 147.0 Hz).
CDCl3): [
d
/ppm] 163.6 (d, 2JCP ¼ 7.2 Hz, C]N), 153.3 (d, JCP ¼ 7.6 Hz,
1H NMR (300.1 MHz, C6D6): [
d/ppm] 7.62e7.60 (m, 2H, Ar),
Ar), 149.2 (s, Ar), 136.2 (s, Ar), 131.8 (br s, Ar), 129.7 (s, Ar), 127.8 (d,
JCP ¼ 10.1 Hz, Ar), 123.5 (s, Ar), 122.6 (s, Ar), 51.6 (s, NCH(CH3)2), 47.0
(s, NCH(CH3)2), 20.4 (s, NCH(CH3)2). DCI[NH3] MS m/z: 404 [M þ H]þ.
7.29e7.18 (m, 3H, Ar), 5.70 (br s, 2H, olefinic HCOD), 3.62 (br s and m,
3H, olefinic HCOD and NCH(CH3)2), 3.38e3.36 (m, 1H, NCH(CH3)2),
2.42 (hd, 3JHH ¼ 7.2 Hz, 2JPH ¼ 7.2 Hz, 2H, PCH(CH3)2), 2.31e2.24 (m,
4H, aliphatic HCOD), 1.88e1.82 (m, 4H, aliphatic HCOD), 1.66e1.56 (m,
Mp: 154e156 ꢁC (dec.). Compound 6: 31P{1H} NMR (121.5 MHz,
1
3
3
CDCl3): [
CDCl3): [
d
/ppm] 45.2 (br d, JPB ¼ 85.4 Hz). 1H NMR (300.1 MHz,
6H, NCH(CH3)2), 1.52 (dd, JHH ¼ 7.2 Hz, JPH ¼ 12.9 Hz, 6H, PCH
3 3
d
/ppm] 8.18 (d, JHH ¼ 5.8 Hz, 1H, Ar), 7.84e7.78 (m, 3H, Ar),
(CH3)2), 1.36 (dd, JHH ¼ 7.2 Hz, JPH ¼ 14.7 Hz, 6H, PCH(CH3)2),
0.79e0.77 (m, 6H, NCH(CH3)2). 13C{1H} NMR (75.5 MHz, C6D6): [
d/
7.57e7.52 (m, 2H, Ar), 7.44e7.39 (m, 4H, Ar), 7.21e7.15 (m, 4H, Ar),
3.78 (h, 3JHH ¼ 6.8 Hz,1H, NCH(CH3)2), 3.22 (h, 3JHH ¼ 6.5 Hz,1H, NCH
ppm] 161.8 (s, C]N),139.6 (d, JCP ¼ 6.7 Hz, Ar),128.4 (s, Ar),128.1 (s,
3
1
2
(CH3)2), 2.4 (br s, 3H, BH3), 1.75 (d, JHH ¼ 6.8 Hz, 3H, NCH(CH3)2),
Ar), 127.8 (s, Ar), 101.4 (dd, JCRh ¼ 6.8 Hz, JCP ¼ 12.8 Hz, CHCOD),
66.1 (d, 1JCRh ¼ 14.2 Hz, CHCOD), 50.4 (br s, NCH(CH3)2), 46.3 (s, NCH
1.68 (d, 3JHH ¼ 6.8 Hz, 3H, NCH(CH3)2),1.41 (d, 3JHH ¼ 6.5 Hz, 3H, NCH
(CH3)2), 1.02 (d, 3JHH ¼ 6.5 Hz, 3H, NCH(CH3)2), 0.50 (br s, 3H, BH3).
3
(CH3)2), 33.3 (d, JCP ¼ 2.6 Hz, CH2COD), 29.7 (d, 1JCP ¼ 25.2 Hz, PCH
CHO
CHO
[Rh(acac)(CO)2]/1,3
+
+
+
H2
CO
Scheme 5. The hydroformylation of styrene.